2020
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response. Blood Adv. 2020;4(20):5146-5156.
Immunomodulation by anticancer cell cycle inhibitors. Nat Rev Immunol. 2020;20(11):669-679.
Deconstructing tumor heterogeneity: the stromal perspective. Oncotarget. 2020;11(40):3621-3632.
Resisting antimicrobial resistance. Nat Rev Microbiol. 2020;18(5):259-260.
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 2020;136(11):1284-1297.
Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists. Am J Surg Pathol. 2020;44(5):673-680.
Cytomorphologic findings of low-grade fibromyxoid sarcoma. J Am Soc Cytopathol. 2020;9(3):191-201.
RGFP966, a histone deacetylase 3 inhibitor, promotes glioma stem cell differentiation by blocking TGF-β signaling via SMAD7. Biochem Pharmacol. 2020;180:114118.
Antibiotic tolerance. PLoS Pathog. 2020;16(10):e1008892.
